CD4 and COVID-19: Within CD4+ T cell meta2cells, this analysis revealed a fine-grained trajectory of phenotypes enriched in patients with critical COVID-19, with T cell phenotypes that correspond meaningfully with disease stage (Fig. 6d,e).